Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laboratories Consolidate Clinical Chemistry and Immunoassay Analyzers

By LabMedica International staff writers
Posted on 09 Dec 2008
An open track-based system will enable laboratories to consolidate and automate sample processing procedures. More...


Laboratory automation provides more efficient sample management, improved laboratory services, and shortened turnaround times. The open track-based system offers medium to large-sized hospital and private laboratories flexibility and access to additional testing capabilities.

Olympus Life Science Europa (Hamburg, Germany) has signed an agreement with Thermo Fisher Scientific (Waltham, MA, USA) for open-track automation for clinical laboratories. The new product offering will complement existing Olympus Laboratory Automation products, including the OLA2500 peri-analytical automation system.

The agreement between the companies will allow laboratory professionals to consolidate Olympus AU-series clinical chemistry and immunoassay analyzers, including various third-party analyzers

Olympus will have the right to distribute Thermo Fisher's TC automation product line, a fully featured, track-based laboratory-automation product line, in the Americas.

Olympus will handle sales and marketing and will provide primary level service and support of the automation products.

By automating the main preanalytical steps, such as centrifugation, decapping, aliquoting and sorting, TC automation helps manage current and future workloads; it interfaces with Olympus systems plus a wide selection of third-party instruments.

Related Links:
Olympus Life Science Europa
Thermo Fisher Scientific



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.